WallStreetZenWallStreetZen

NASDAQ: BNTC
Benitec Biopharma Inc Stock

$7.48+0.01 (+0.13%)
Updated Jun 13, 2024
BNTC Price
$7.48
Fair Value Price
$0.75
Market Cap
$70.07M
52 Week Low
$1.86
52 Week High
$10.70
P/E
-76.33x
P/B
6.09x
P/S
1,962.21x
PEG
N/A
Dividend Yield
N/A
Revenue
$7.00k
Earnings
-$21.69M
Gross Margin
100%
Operating Margin
-309,542.86%
Profit Margin
-309,885.7%
Debt to Equity
0.3
Operating Cash Flow
-$20M
Beta
0.53
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

BNTC Overview

Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BNTC scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BNTC ($7.48) is overvalued by 901.17% relative to our estimate of its Fair Value price of $0.75 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
BNTC ($7.48) is not significantly undervalued (901.17%) relative to our estimate of its Fair Value price of $0.75 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
BNTC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more BNTC due diligence checks available for Premium users.

Be the first to know about important BNTC news, forecast changes, insider trades & much more!

BNTC News

Valuation

BNTC fair value

Fair Value of BNTC stock based on Discounted Cash Flow (DCF)
Price
$7.48
Fair Value
$0.75
Overvalued by
901.17%
BNTC ($7.48) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
BNTC ($7.48) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
BNTC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

BNTC price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-76.33x
Industry
-7.95x
Market
30.48x

BNTC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
6.09x
Industry
6.3x
BNTC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

BNTC's financial health

Profit margin

Revenue
$0.0
Net Income
-$4.3M
Profit Margin
0%
BNTC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
BNTC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$15.0M
Liabilities
$3.5M
Debt to equity
0.3
BNTC's short-term assets ($14.37M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BNTC's short-term assets ($14.37M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BNTC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$6.2M
Investing
-$179.0k
Financing
$0.0
BNTC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

BNTC vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
BNTC$70.07M+0.13%-76.33x6.09x
CSBR$70.01M+3.83%-7.15x-34.02x
ALRN$70.17M0.00%-1.01x0.77x
CVM$69.87M-3.01%-2.05x4.88x
RLYB$68.81M+0.61%-0.89x0.77x

Benitec Biopharma Stock FAQ

What is Benitec Biopharma's quote symbol?

(NASDAQ: BNTC) Benitec Biopharma trades on the NASDAQ under the ticker symbol BNTC. Benitec Biopharma stock quotes can also be displayed as NASDAQ: BNTC.

If you're new to stock investing, here's how to buy Benitec Biopharma stock.

What is the 52 week high and low for Benitec Biopharma (NASDAQ: BNTC)?

(NASDAQ: BNTC) Benitec Biopharma's 52-week high was $10.70, and its 52-week low was $1.86. It is currently -30.09% from its 52-week high and 302.15% from its 52-week low.

How much is Benitec Biopharma stock worth today?

(NASDAQ: BNTC) Benitec Biopharma currently has 9,367,485 outstanding shares. With Benitec Biopharma stock trading at $7.48 per share, the total value of Benitec Biopharma stock (market capitalization) is $70.07M.

Benitec Biopharma stock was originally listed at a price of $1,354.90 in Aug 18, 2015. If you had invested in Benitec Biopharma stock at $1,354.90, your return over the last 8 years would have been -99.45%, for an annualized return of -47.79% (not including any dividends or dividend reinvestments).

How much is Benitec Biopharma's stock price per share?

(NASDAQ: BNTC) Benitec Biopharma stock price per share is $7.48 today (as of Jun 13, 2024).

What is Benitec Biopharma's Market Cap?

(NASDAQ: BNTC) Benitec Biopharma's market cap is $70.07M, as of Jun 15, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Benitec Biopharma's market cap is calculated by multiplying BNTC's current stock price of $7.48 by BNTC's total outstanding shares of 9,367,485.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.